KalVista Pharmaceuticals, Inc. (KALV)

Typically moves ±4.96% on earnings

EARNINGS ANALYTICS

notifications_active EARNINGS TODAY (2026-09-08)

Since May 21, 2015, KalVista Pharmaceuticals, Inc. (KALV) has reported earnings 31 times. On average the shares move ±4.96% post-earnings, with a positive reaction 35.5% of the time. Its largest post-earnings gain was +10.5% (Jul 31, 2018) and its largest decline was -14.81% (Mar 10, 2020). The next earnings report is predicted for 2026-09-08 (today).

Earnings reactions

How KALV moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±4.96%

Positive %

35.5%

Negative %

64.5%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Mar 25, 2026	☀ PRE	+4.13%	open_in_new
Nov 10, 2025	☽ POST	+5.33%	open_in_new
Sep 11, 2025	☀ PRE	-3.77%	open_in_new
Mar 12, 2025	☽ POST	-1.61%	open_in_new
Dec 05, 2024	☽ POST	+8.34%	open_in_new
Sep 05, 2024	☽ POST	-4.12%	open_in_new
Mar 11, 2024	☽ POST	-4.66%	open_in_new
Dec 07, 2023	☽ POST	-9.03%	open_in_new
Sep 07, 2023	☽ POST	-4.52%	open_in_new
Mar 09, 2023	☽ POST	-5.31%	open_in_new
Dec 08, 2022	☽ POST	+4.57%	open_in_new
Sep 08, 2022	☽ POST	+0.19%	open_in_new
Mar 10, 2022	☽ POST	-6.04%	open_in_new
Dec 09, 2021	☽ POST	-1.6%	open_in_new
Sep 09, 2021	☽ POST	-4.31%	open_in_new
Mar 11, 2021	☽ POST	+4.87%	open_in_new
Dec 10, 2020	☽ POST	+7.42%	open_in_new
Sep 14, 2020	☽ POST	-0.79%	open_in_new
Mar 10, 2020	☽ POST	-14.81%	open_in_new
Dec 03, 2019	☽ POST	-2.74%	open_in_new
Sep 09, 2019	☽ POST	-1.02%	open_in_new
Mar 14, 2019	☽ POST	-6.91%	open_in_new
Dec 14, 2018	☀ PRE	-3.04%	open_in_new
Jul 31, 2018	☀ PRE	+10.5%	open_in_new
Mar 16, 2018	☀ PRE	+9.22%	open_in_new
Dec 14, 2017	☀ PRE	-7.81%	open_in_new
Sep 14, 2017	☽ POST	-13.11%	open_in_new
Mar 17, 2017	☽ POST	-2.47%	open_in_new
Nov 12, 2015	☽ POST	-0.25%	open_in_new
Aug 12, 2015	☽ POST	+0.81%	open_in_new
May 21, 2015	☽ POST	+0.4%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±4.96%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2026 · SEC 13-F

View all 2 →

Funds holding

$219580

Total value held

Buying

2 added · 0 reduced

Janus Henderson Group Plc

$219526 NEW BUY

Amalgamated Financial Corp.

$54 NEW BUY

SEC Filing Types

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
SCHEDULE 13G	20260811	open_in_new SEC.gov
15-12G	20260622	open_in_new SEC.gov
EFFECT	20260616	open_in_new SEC.gov
25-NSE	20260611	open_in_new SEC.gov
4	20260611	open_in_new SEC.gov
4	20260611	open_in_new SEC.gov
4	20260611	open_in_new SEC.gov

Frequently asked about KALV earnings

When does KalVista Pharmaceuticals, Inc. report earnings next? expand_more

KalVista Pharmaceuticals, Inc. (KALV)'s next earnings date is predicted for today for 2026-09-08. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does KALV stock move after earnings? expand_more

Over 31 reports, KALV has moved an average of ±4.96% the session after earnings, closing higher 35.5% of the time.

What was KALV's biggest post-earnings move? expand_more

KALV's largest post-earnings gain on record was +10.5% on Jul 31, 2018, and its largest decline was -14.81% on Mar 10, 2020.

Where can I find KalVista Pharmaceuticals, Inc.'s SEC filings? expand_more

All of KalVista Pharmaceuticals, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.